FULC

FULC

Fulcrum Therapeutics Inc. Common Stock

$6.805+0.000 (0.000%)

Precio en Tiempo Real

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$6.805

Máximo

$6.805

Mínimo

$6.805

Volumen

0.69M

Fundamentos de la Empresa

Estadísticas de Negociación

Noticias Relacionadas

GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with

Ver más
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Analyst Upgrades

Leerink Partners Upgrades Fulcrum Therapeutics to Outperform, Raises Price Target to $12

Leerink Partners analyst Joseph Schwartz upgrades Fulcrum Therapeutics from Market Perform to Outperform and raises the price target from $4 to $12.

Ver más
Leerink Partners Upgrades Fulcrum Therapeutics to Outperform, Raises Price Target to $12